I found the discussion on IP interesting, but the main advantage of such a distribution list over Twitter is its higher signal to noise ratio (SNR). Next to the better ability to express oneself without character limits.
When a discussion moves off topic, I would not be too strict, but when it already starts off topic it may be good to think of the SNR. For me the GOAL list is a useful resource for information to put on the Open Science Feed. So I hope it continues. https://reddit.com/r/Open_Science/ On 03/09/2021 21:15, Richard Poynder wrote: > “GOAL may or may not be the right venue for this discussion. Advice on > this would be welcome.” > > > >>>>> > > > > On this question, on the role of GOAL, and on the future of the list I > am happy to hear the views of list members. > > > > I have been thinking about the future of GOAL for a while now. As the > name signals, it was set up to discuss open access. More specifically, > the description of the list says that it is “dedicated to the discussion > of Open Access practice and policy-making by the worldwide research > community (in no order: researchers, universities, research > institutions, research funding agencies, governmental research > policy-makers and commercial entities) with the aim of enabling > concrete, practical steps to be taken to achieve Open Access. Chief > among these goals are techniques for increasing the amount of Open > Access, as well as metrics of research usage and impact.” > > > > However, discussions about open access have now become mainstream and > the reality is that much of the debate tends to take place elsewhere > today, not least on Twitter. > > > > I am happy to continue moderating the list, I am happy for the list to > continue as it is. I am also happy to discuss GOAL’s focus, its role and > its future. But I think this would need to be a discussion that members > of the list were involved in. > > > > All thoughts/suggestions are welcomed. > > > > Best wishes, > > > > > > Richard Poynder > > GOAL Moderator > > > > > > *From:*[email protected] <[email protected]> *On Behalf Of > *Heather Morrison > *Sent:* 03 September 2021 16:14 > *To:* Global Open Access List (Successor of AmSci) <[email protected]> > *Subject:* Re: [GOAL] COVID IP waiver request: interesting but not > entirely informed? > > > > Thank you, Ulrich. > > > > The exception does look like it would be helpful in an emergency like > COVID, and likely necessary as the default is an expectation of > protection of rights and commercial exploitation; this is also on p. 102. > > > > There is a sharp contrast in the E.U. and North America between success > in achieving OA as the default in dissemination of results and > expectation of protecting IP for commercial exploitation. It would be > interesting to have meaningful and informed discussion about this. To > participate in informed discussion, participants should understand the > basics about the different types of IP. For those who may be new to this > area, WIPO's "What is intellectual property" page is a good starting point: > > https://www.wipo.int/about-ip/en/ <https://www.wipo.int/about-ip/en/> > > > > The Public Library of Science (PLOS) Terms of Use may also be helpful to > OA advocates in understanding the different types of IP. Like most fully > OA publishers with a firm commitment to open licensing, PLOS is very > protective of their own work, including their own text on the website > and their trademark. > > https://www.wipo.int/about-ip/en/ > <https://emea01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.wipo.int%2Fabout-ip%2Fen%2F&data=04%7C01%7C%7C6047b050d87042b8099f08d96f0ab903%7C84df9e7fe9f640afb435aaaaaaaaaaaa%7C1%7C0%7C637662914109834028%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&sdata=Hz1za3hvUkRVKMxVVUOh0L9Y9y1eTHr%2B0HfIkb8wrrw%3D&reserved=0> > > > > The Google business model of advertising-supported facilitated access to > free knowledge and services created by others, made possible by > algorithms carefully protected as trade secrets, is another example of > how different the various types of IP are. It is not unusual for a > single internet search to invoke multiple different types of IP that > work in very different fashion. > > > > COVID is an interesting case study. My impression (not based on > substantive research) is that the world, including the traditional > commercial scholarly publishing industry, has made considerable progress > in open sharing of information about the virus. There is no doubt still > a great deal of room for improvement, but this is an advance and should > be celebrated as much. I wonder how much the success of the OA / open > data movements to date contributed to the rapid development of COVID > vaccines in multiple countries. > > > > Manufacturing involves patent law, and the manufacturing industries are > very different from scholarly publishing. In the case of COVID vaccine > manufacture, even under the current licensing regime, we have instances > of what looks to me (as a non-expert) like rapid implementation of > manufacture (Johnson & Johnson in Baltimore, more recently a Moderna > factory in Spain creating doses for Japan) resulting in contaminated > vaccines. This is not helpful in a context where vaccine hesitancy and > an anti-vaccination movement are significant barriers to addressing > COVID. In this case, simply opening up the rights to manufacture > vaccines to anyone could do more harm than good. > > > > On the other hand, the profit-driven pharma-as-usual model may be > driving a push for booster shots in rich countries that may not be > necessary, when the most compassionate and smartest approach (even for > the rich countries) is likely shots in arms everywhere (to reduce > opportunities for new variants to develop). I see this as a good > opportunity for discussion on how IP works in this area and how to do it > better. Lessons from the OA movement may or may not be relevant, but > understanding how to produce and distribute quality vaccines and other > medicines is absolutely essential for informed discussion in this area. > > > > GOAL may or may not be the right venue for this discussion. Advice on > this would be welcome. > > > > best, > > > > Dr. Heather Morrison > > Associate Professor, School of Information Studies, University of Ottawa > > Cross-appointed, Department of Communication > > Professeur Agrégé, École des Sciences de l'Information, Université d'Ottawa > > Principal Investigator, Sustaining the Knowledge Commons, a SSHRC > Insight Project > > sustainingknowledgecommons.org > > [email protected] <mailto:[email protected]> > > https://uniweb.uottawa.ca/?lang=en#/members/706 > <https://emea01.safelinks.protection.outlook.com/?url=https%3A%2F%2Funiweb.uottawa.ca%2F%3Flang%3Den%23%2Fmembers%2F706&data=04%7C01%7C%7C6047b050d87042b8099f08d96f0ab903%7C84df9e7fe9f640afb435aaaaaaaaaaaa%7C1%7C0%7C637662914109834028%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&sdata=tPGz85O764Yv%2FlxZZOMDPOTxjSJuZqYFtJx%2FEgUtbd0%3D&reserved=0> > > > > ------------------------------------------------------------------------ > > *From:*Ulrich Herb <[email protected] > <mailto:[email protected]>> > *Sent:* Friday, September 3, 2021 7:36 AM > *To:* goal <[email protected] <mailto:[email protected]>> > *Cc:* Heather Morrison <[email protected] > <mailto:[email protected]>> > *Subject:* Re: [GOAL] COVID IP waiver request: interesting but not > entirely informed? > > > > Attention : courriel externe | external email > > perhaps this might be of interest: in its new research framework > programme Horizon Europe the European Commission states this > (https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/agr-contr/general-mga_horizon-euratom_en.pdf > <https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/agr-contr/general-mga_horizon-euratom_en.pdf>, > p. 102) ... > *** > Where the call conditions impose additional exploitation obligations in > case of a public > emergency, the beneficiaries must (if requested by the granting > authority) grant for a limited > period of time specified in the request, non-exclusive licences — under > fair and reasonable > conditions — to their results to legal entities that need the results to > address the public > emergency and commit to rapidly and broadly exploit the resulting > products and services at > fair and reasonable conditions. This provision applies up to four years > after the end of the > action. > *** > > As there was no such statement in the model grant agreements of earlier > framework programmes, I interpret this regulation a direct reaction to > the COVID pandemic... > > > Best regards > > Ulrich > > ----- Am 2. Sep 2021 um 22:07 schrieb Federico Leva (Nemo) > [email protected] <mailto:[email protected]>: > > Il 01/09/21 23:25, Heather Morrison ha scritto: >> The WHO letter mentions but does not request what I suggest is a more > likely approach to avoiding IP interference with addressing the pandemic > in the short term: compulsory licensing. > > This is the official reason used by the EU to block the waiver (or at > least it was until Biden came out in support of it and force everyone to > change tune). > https://www.keionline.org/36300 > <https://emea01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.keionline.org%2F36300&data=04%7C01%7C%7C6047b050d87042b8099f08d96f0ab903%7C84df9e7fe9f640afb435aaaaaaaaaaaa%7C1%7C0%7C637662914109834028%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&sdata=CbuQ5jo0tThbTcZzFWUZrhIvAp01tUxnMUJV3MwrchM%3D&reserved=0> > > It's true that the USA could easily implement compulsory licensing > overnight, but for other countries it can prove more difficult. There > are dozens of articles in the KEI website on this matter, I'm unable to > summarise them. It's highly recommended reading. > > Communia, Wikimedia and others have also supported the extension of > waiver to copyright, see most recently: > https://www.communia-association.org/2021/03/22/communia-supports-the-wto-trips-waiver-for-covid-19/ > <https://emea01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.communia-association.org%2F2021%2F03%2F22%2Fcommunia-supports-the-wto-trips-waiver-for-covid-19%2F&data=04%7C01%7C%7C6047b050d87042b8099f08d96f0ab903%7C84df9e7fe9f640afb435aaaaaaaaaaaa%7C1%7C0%7C637662914109843985%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&sdata=COgxq9m0iE%2B9d5zL%2FDERmUuczfzB1fevEp0zMdNWPJk%3D&reserved=0> > > Best regards, > Federico > _______________________________________________ > GOAL mailing list > [email protected] <mailto:[email protected]> > http://mailman.ecs.soton.ac.uk/mailman/listinfo/goal > <https://emea01.safelinks.protection.outlook.com/?url=http%3A%2F%2Fmailman.ecs.soton.ac.uk%2Fmailman%2Flistinfo%2Fgoal&data=04%7C01%7C%7C6047b050d87042b8099f08d96f0ab903%7C84df9e7fe9f640afb435aaaaaaaaaaaa%7C1%7C0%7C637662914109843985%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&sdata=PXuwCDcLrGw3NooqmeL7M4%2FdLD77VFokLJsAYxMtDjQ%3D&reserved=0> > -- > Mit freundlichen Grüßen > > Dr. Ulrich Herb > Saarländische Universitäts- und Landesbibliothek > Referent für elektronisches Publizieren und Open Access, > Drittmittel-Projekte > > Postanschrift: Postfach 15 11 41 | 66041 Saarbrücken > > Besucheranschrift: Campus B1 1 | Raum 10.07. | 66123 Saarbrücken > > T: +49 681 302-2798 > F: +49 681 302-2796 > [email protected] <mailto:[email protected]> > www.sulb.uni-saarland.de > <https://emea01.safelinks.protection.outlook.com/?url=http%3A%2F%2Fwww.sulb.uni-saarland.de%2F&data=04%7C01%7C%7C6047b050d87042b8099f08d96f0ab903%7C84df9e7fe9f640afb435aaaaaaaaaaaa%7C1%7C0%7C637662914109853942%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&sdata=0yF0B2y3HVhGanr4R0AWYrxbDrV2rSc8CqVNlylDJKw%3D&reserved=0> > > > _______________________________________________ > GOAL mailing list > [email protected] > http://mailman.ecs.soton.ac.uk/mailman/listinfo/goal > -- <>-<>-<>-<>-<>-<>-<>-<>-<>-<>-<>-<>-<>-<>-<>-<>-<>-<>-<>-<>-<>-<>-<>-<> Victor VENEMA Grassroots Journals https://grassroots.is E-mail: [email protected] E-mail: [email protected] Homepage: http://www2.meteo.uni-bonn.de/victor Blog: http://variable-variability.blogspot.com Mastodon: https://fediscience.org/@VictorVenema Twitter: https://twitter.com/VariabilityBlog Matrix: @viv:datenburg.org GIT: https://codeberg.org/Venema GitHub: https://github.com/VictorVenema/ https://twitter.com/Grassr_Journals https://fediscience.org/@OpenScienceFeed https://twitter.com/OpenScienceR There is no need to answer my mails in your free time. <>-<>-<>-<>-<>-<>-<>-<>-<>-<>-<>-<>-<>-<>-<>-<>-<>-<>-<>-<>-<>-<>-<>-<> _______________________________________________ GOAL mailing list [email protected] http://mailman.ecs.soton.ac.uk/mailman/listinfo/goal
